Balyasny Asset Management L.P.

Position in AXGN — Axogen, Inc.

CIK 1218710 Chicago, IL

Position in AXGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$36,014,495

+$8,277,326 QoQ

Shares Held

1,087,066

+28.3% QoQ

Ownership

2.04%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $878,026,211 across 43 Medical Devices names. AXGN ranks #7 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	762,096	$250,249,463
2	MASI	Masimo Corp	770,986	$137,135,279
3	ABT	Abbott Laboratories	844,451	$86,699,784
4	BSX	Boston Scientific Corp	1,356,133	$85,097,345
5	BRKR	Bruker Corp	1,159,040	$41,864,524
6	ZBH	Zimmer Biomet Holdings, Inc.	424,578	$38,390,342
7	AXGN	Axogen, Inc. This page	1,087,066	$36,014,495
8	DXCM	Dexcom Inc	566,312	$35,564,393

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$36,014,495	1,087,066	+28.3%	Shares	Sole	2026-05-15
2025-12-31	$27,737,169	847,454	-38.6%	Shares	Sole	2026-02-17
2025-09-30	$24,612,813	1,379,642	-28.6%	Shares	Sole	2025-11-14
2025-06-30	$20,953,064	1,931,158	+183.9%	Shares	Sole	2025-08-14
2025-03-31	$12,583,515	680,190	+126.8%	Shares	Sole	2025-05-15
2024-12-31	$4,943,044	299,942	+1241.7%	Shares	Sole	2025-02-14
2023-06-30	$204,110	22,356	-84.0%	Shares	Sole	2023-08-14
2022-03-31	$1,110,424	139,852	-54.8%	Shares	Sole	2022-05-16
2021-12-31	$2,897,456	309,227	+53.1%	Shares	Sole	2022-02-14
2021-09-30	$3,191,173	201,973	-43.1%	Shares	Sole	2021-12-01
2021-06-30	$7,671,787	355,011	+42.4%	Shares	Sole	2021-08-16
2021-03-31	$5,049,825	249,251	+148.0%	Shares	Sole	2021-05-17
2020-12-31	$1,798,735	100,488	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.